Director Joseph Whitters Acquires 100,000 Shares of Accuray Inc
ARAY Stock | USD 2.15 0.08 3.59% |
Slightly above 69% of Accuray Incorporated's investor base is looking to short. The analysis of overall sentiment of trading Accuray Incorporated stock suggests that many investors are alarmed at this time. Accuray Incorporated's investing sentiment can be driven by a variety of factors including economic data, Accuray Incorporated's earnings reports, geopolitical events, and overall market trends.
Accuray |
On May 29, 2024, Joseph Whitters, Director at Accuray Inc , purchased 100,000 shares of the company, as reported in a recent SEC Filing. Following this tr
Read at gurufocus.com
Accuray Incorporated Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Accuray Incorporated can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Accuray Incorporated Fundamental Analysis
We analyze Accuray Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accuray Incorporated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accuray Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Accuray Incorporated is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Accuray Incorporated Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accuray Incorporated stock to make a market-neutral strategy. Peer analysis of Accuray Incorporated could also be used in its relative valuation, which is a method of valuing Accuray Incorporated by comparing valuation metrics with similar companies.
Peers
Accuray Incorporated Related Equities
APYX | Apyx Medical | 18.01 | ||||
NPCE | Neuropace | 6.51 | ||||
AXGN | Axogen | 4.75 | ||||
CTSO | Cytosorbents Crp | 3.09 | ||||
AVNS | Avanos Medical | 2.30 | ||||
SGHT | Sight Sciences | 0.75 | ||||
SRDX | SurModics | 0.41 | ||||
AORT | Artivion | 0.34 | ||||
FNA | Paragon 28 | 0.1 | ||||
BVS | Bioventus | 0.08 | ||||
KIDS | Orthopediatrics Corp | 0.19 | ||||
ANIK | Anika Therapeutics | 0.96 | ||||
CLPT | Clearpoint Neuro | 1.05 | ||||
OFIX | Orthofix Medical | 1.13 | ||||
SIBN | Si Bone | 1.40 | ||||
TELA | Tela Bio | 4.78 | ||||
CUTR | Cutera | 10.20 |
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.